Acute Transverse Myelitis after COVID-19 Vaccination.
Yu-Ting HsiaoMing-Jen TsaiYing-Hao ChenChi-Feng HsuPublished in: Medicina (Kaunas, Lithuania) (2021)
The adverse effects of the COVID-19 vaccine have been discovered as the rapid application of the vaccines continues. Neurological complications such as transverse myelitis raise concerns as cases were observed in clinical trials. Transverse myelitis is a rare immune-mediated disease with spinal cord neural injury, resulting in neurological deficits in the motor, sensory, and autonomic system. Vaccine-related transverse myelitis is even rarer. We present a case of acute transverse myelitis after vaccination against COVID-19 with the ChAdOx1 nCOV-19 vaccine (AZD1222), which was the first case reported in Taiwan. Although it rarely occurs, post-vaccination neurological complications should not be ignored. As the pandemic of SARS-CoV-2 continues to spread and concern about vaccination efficacy and safety rises, heterologous vaccination were implemented in health public policy in several countries. A literature review of several clinical trials shows promising effects of mix-and-match vaccination. Further study on different combinations of vaccines can be expected.
Keyphrases
- sars cov
- coronavirus disease
- clinical trial
- healthcare
- spinal cord
- respiratory syndrome coronavirus
- public health
- liver failure
- mental health
- respiratory failure
- traumatic brain injury
- heart rate variability
- case report
- risk assessment
- emergency department
- phase ii
- open label
- health information
- electronic health record
- extracorporeal membrane oxygenation
- mechanical ventilation
- cerebral ischemia
- human health
- double blind
- loop mediated isothermal amplification